North America Immunoassay Reagents And Devices Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2028 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 6.68 Billion |
 CAGR |
% |
| Major Markets Players |
|
北美免疫测定试剂和设备市场，按产品（试剂和试剂盒、分析仪）、平台（化学发光免疫测定、荧光免疫测定、酶免疫测定、放射免疫测定等）、技术（酶联免疫吸附测定、快速检测、酶联免疫斑点、蛋白质印迹、免疫 PCR 等技术）、样本类型（血液、尿液、唾液等）、应用（传染病、肿瘤学和内分泌学、骨骼和矿物质疾病、心脏病学、血液学和血液筛查、自身免疫性疾病、毒理学、新生儿筛查等应用）、最终用户（医院、临床实验室、制药和生物技术公司、血库、研究和学术实验室等）、国家（美国、加拿大、墨西哥）行业趋势和预测2028 年。
市场分析和见解：北美免疫测定试剂和设备市场
免疫测定试剂和设备市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，市场将以 4.7% 的复合年增长率增长，预计到 2028 年将达到 101.7881 亿美元。疾病患病率的上升需要技术先进的产品进行诊断以避免误解，预计将在预测期内推动免疫测定试剂和设备市场的增长。
免疫测定是在实验室中检测特定分子的测试。它基本上取决于抗体附着在样本中存在的分子（抗原）的特定结构上的整体能力。抗体是在体内对抗原的存在作出反应而产生的。
COVID-19 疫情的出现导致了使用免疫测定技术的快速诊断检测 (RDT) 的制造，预计这将成为免疫测定试剂和设备市场增长的驱动力。产品召回会产生负面影响，因为制造商会投入大量资金来更换或修理有缺陷的产品，进而导致收入下降。因此，这可能是预测期内免疫测定试剂和设备市场发展的主要制约因素。为了向市场提供增强型或新产品，预计免疫测定试剂和设备研究和开发的增加将为预测期内免疫测定试剂和设备市场的增长创造机会之窗。液相色谱-质谱技术作为检测生物分子的免疫测定替代方法的存在，预计将对免疫测定试剂和设备市场的增长构成挑战。
免疫测定试剂和设备市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和免疫测定试剂和设备市场情况，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预期目标。
免疫测定试剂和设备市场范围和市场规模
免疫测定试剂和设备市场根据产品、平台、技术、样本类型、应用和最终用户进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据产品，免疫测定试剂和设备市场细分为试剂和试剂盒以及分析仪。2021 年，试剂和试剂盒领域占据主导地位，因为它在药物开发和疾病检测中的使用率较高。
- 根据平台，免疫测定试剂和设备市场细分为化学发光免疫测定、荧光免疫测定、酶免疫测定、放射免疫测定等。2021 年，酶免疫测定领域占据市场主导地位，因为它具有测试简便、结果准确等诸多优势。
- 根据技术，免疫测定试剂和设备市场细分为酶联免疫吸附测定、快速检测、酶联免疫斑点、蛋白质印迹、免疫 PCR 和其他技术。2021 年，酶联免疫吸附测定领域占据主导地位，因为它灵敏度高、操作简单，可为任何疾病检测或任何药物开发提供准确的结果。
- 根据样本类型，免疫测定试剂和设备市场分为唾液、尿液、血液和其他。2021 年，血液部分占据市场主导地位，因为可以从血液中轻松检测到抗原。
- 根据应用，免疫测定试剂和设备市场细分为传染病、肿瘤学和内分泌学、骨骼和矿物质疾病、心脏病学、血液学和血液筛查、自身免疫性疾病、毒理学、新生儿筛查和其他应用。2021 年，肿瘤学和内分泌学领域占据主导地位，因为全球发病率很高，可以通过免疫测定轻松检测出来。
- 根据最终用户，免疫测定试剂和设备市场细分为医院、临床实验室、制药和生物技术公司、血库、研究和学术实验室等。2021 年，制药和生物技术公司部门将占据市场主导地位，因为免疫测定在药物开发中的使用率很高。
北美 免疫测定试剂和设备市场国家级分析
对北美免疫测定试剂和设备市场进行了分析，并按国家、产品、平台、技术、样本类型、应用和最终用户提供了市场规模信息。
北美免疫测定试剂和设备市场报告涵盖的国家包括美国、加拿大和墨西哥。
由于许多生物技术和制药行业对检测和药物开发的偏好日益增加，美国的平台部分在北美免疫测定试剂和设备市场中占据主导地位。而加拿大则因增加研发以提供更优质的产品而占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
主要市场参与者不断增加的战略活动提高了人们对免疫测定试剂和设备的认识，从而推动了免疫测定试剂和设备市场的发展
免疫测定试剂和设备市场还为您提供有关每个国家免疫测定试剂和设备市场增长的详细免疫测定试剂和设备市场分析。此外，它还提供有关免疫测定试剂和设备市场参与者的战略及其地理分布的详细信息。数据适用于 2011 年至 2019 年的历史时期。
竞争格局和免疫测定试剂和设备市场份额分析
免疫测定试剂和设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对北美免疫测定试剂和设备市场的关注有关。
北美免疫测定试剂和设备市场报告的主要公司包括 F. Hoffmann-La Roche Ltd、Siemens、Randox Laboratories Ltd.、Abbott、Bio-Rad Laboratories, Inc.、Merck KGaA、Beckman Coulter, Inc.（Danaher 的子公司）、Sysmex Corporation、bioMérieux SA、Thermo Fisher Scientific, Inc.、BD、深圳迈瑞生物医疗电子股份有限公司、DiaSorin SpA、Ortho Clinical Diagnostics、QIAGEN、Quidel Corporation、BioCheck, Inc.、Bio-Techne、PerkinElmer Inc.、Agilent Technologies, Inc.、Luminex Corporation、MESO SCALE DIAGNOSTICS, LLC 以及其他国内公司。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。
全球各地的公司还签订了许多合同、协议和发布，这也加速了免疫测定试剂和设备市场的发展。
例如，
- 2020 年 7 月，生命科学研究和临床诊断产品的全球领导者 Bio-Rad Laboratories, Inc. 宣布，该公司将推出一种基于血液的免疫测定试剂盒，用于识别与 COVID-19 相关的冠状病毒 SARS-CoV-2 的抗体。该检测的初步性能已经确定，目前该试剂盒正在多家医院进行临床评估，以进一步确认临床性能。从 700 多个样本收集的初步数据显示特异性超过 99%。
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业等策略正在增强公司在免疫测定试剂和设备市场的影响力，这也为组织的利润增长带来了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 INDUSTRY INSIGHTS
5.1 NEW PRODUCT LAUNCHES:
5.2 REGULATIONS FOR IMMUNOASSAY REAGENT AND DEVICE MARKET –
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING INCIDENCE OF CHRONIC AND INFECTIOUS DISEASES IN NORTH AMERICA
6.1.2 EMERGENCE OF COVID-19 PANDEMIC IN NORTH AMERICA
6.1.3 WIDE APPLICATION OF IMMUNOASSAY IN NORTH AMERICA
6.1.4 INCREASING HEALTHCARE EXPENDITURE IN NORTH AMERICA
6.1.5 WIDE USE IN DRUG SCREENING TESTS IN NORTH AMERICA
6.2 RESTRAINTS
6.2.1 HIGH COST OF IMMUNOASSAY KITS AND DEVICES IN NORTH AMERICA
6.2.2 PRODUCT RECALL OF IMMUNOASSAY KITS AND DEVICES IN NORTH AMERICA
6.3 OPPORTUNITIES
6.3.1 INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES
6.3.2 STRATEGIC INITATIVES BY THE COMPANIES
6.3.3 TECHNOLOGICAL UPGRADATION AND ADVANCEMENTS IN BIOTECHNOLOGY
6.4 CHALLENGES
6.4.1 AVAILABILITY OFALTERNATIVE TECHNOLOGIES
6.4.2 COMPLEXICITY IN PERFORMING IMMUNOASSAY
7 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 REAGENTS & KITS
7.2.1 ELISA REAGENTS & KITS
7.2.1.1 THIRD-GENERATION ELISA
7.2.1.2 FIFTH-GENERATION ELISA
7.2.1.3 FOURTH-GENERATION ELISA
7.2.1.4 FIRST-GENERATION ELISA
7.2.1.5 SECOND-GENERATION ELISA
7.2.2 ELISPOT REAGENTS & KITS
7.2.3 RAPID TEST REAGENTS & KITS
7.2.4 WESTERN BLOT REAGENTS & KITS
7.2.5 OTHER REAGENTS & KITS
7.3 ANALYZERS
7.3.1 BY TYPE
7.3.1.1 OPEN-ENDED SYSTEMS
7.3.1.2 CLOSED-ENDED SYSTEMS
7.3.2 BY DEVICE TYPE
7.3.2.1 BENCH-TOP
7.3.2.2 FLOOR STANDING
8 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM
8.1 OVERVIEW
8.2 ENZYME IMMUNOASSAY
8.3 FLUORESCENCE IMMUNOASSAYS
8.4 CHEMILUMINESCENCE IMMUNOASSAYS
8.5 RADIOIMMUNOASSAYS
8.6 OTHERS
9 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE
9.1 OVERVIEW
9.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS
9.3 ENZYME-LINKED IMMUNOSPOT
9.4 RAPID TESTS
9.5 WESTERN BLOTTING
9.6 IMMUNO-PCR
9.7 OTHER TECHNIQUES
10 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE
10.1 OVERVIEW
10.2 BLOOD
10.3 URINE
10.4 SALIVA
10.5 OTHERS
11 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ONCOLOGY AND ENDOCRINOLOGY
11.3 HEMATOLOGY & BLOOD SCREENING
11.4 CARDIOLOGY
11.5 INFECTIOUS DISEASES
11.6 BONE & MINERAL DISORDERS
11.7 AUTOIMMUNE DISORDERS
11.8 TOXICOLOGY
11.9 NEONATAL SCREENING
11.1 OTHER APPLICATIONS
12 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER
12.1 OVERVIEW
12.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.3 CLINICAL LABORATORIES
12.4 HOSPITALS
12.5 RESEARCH & ACADEMIC LABORATORIES
12.6 BLOOD BANKS
12.7 OTHERS
13 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY REGION
13.1 NORTH AMERICA MARKET
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 COMPANY PROFILE
15.1 F. HOFFMANN-LA ROCHE LTD
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 ABBOTT
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 2.3 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 DIASORIN S.P.A
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 PERKINELMER INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 BIOMÉRIEUX SA
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 AGILENT TECHNOLOGIES, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 BD
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 BECKMAN COULTER, INC (A SUBSIDIARY OF DANAHER)
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 BIOCHECK, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BIO-TECHNE
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENTS
15.11 BIO-RAD LABORATORIES, INC.
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENTS
15.12 LUMINEX CORPORATION
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 MERCK KGAA
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 MESO SCALE DIAGNOSTICS, LLC
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 ORTHO CLINICAL DIAGNOSTICS
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 QIAGEN
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 QUIDEL CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENTS
15.18 RANDOX LABORATORIES LTD.
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 SIEMENS
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
15.21 SYSMEX CORPORATION
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 THERMO FISHER SCIENTIFIC INC.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PORTFOLIO
15.22.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 COST OF ELISA KITS BY CELL SCIENCES, INC.
TABLE 2 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 23 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 24 U.S. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 25 U.S. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 26 U.S. REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 27 U.S. ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 28 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 29 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 30 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 31 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 32 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 33 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 34 CANADA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 35 CANADA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 36 CANADA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 37 CANADA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 39 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 40 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 41 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 42 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 43 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 44 MEXICO ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 45 MEXICO ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 46 MEXICO REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 MEXICO ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 48 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 49 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 50 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 51 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 52 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : DATA TRIANGULATION
FIGURE 3 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : DROC ANALYSIS
FIGURE 4 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NOTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SEGMENTATION
FIGURE 11 INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 REAGENTS & KITS SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET
FIGURE 14 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT, 2020
FIGURE 15 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PLATFORM, 2020
FIGURE 16 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY TECHNIQUE, 2020
FIGURE 17 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY SPECIMEN TYPE, 2020
FIGURE 18 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY APPLICATION, 2020
FIGURE 19 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY END USER, 2020
FIGURE 20 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2020)
FIGURE 21 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020)
FIGURE 22 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 23 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 24 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2021 & 2028)
FIGURE 25 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
